RLAY logo

Relay Therapeutics, Inc. (RLAY) EBIT

Annual EBIT:

-$385.67M-$6.25M(-1.65%)
December 31, 2024

Summary

  • As of today, RLAY annual earnings before interest & taxes is -$385.67 million, with the most recent change of -$6.25 million (-1.65%) on December 31, 2024.
  • During the last 3 years, RLAY annual EBIT has fallen by -$158.67 million (-69.90%).
  • RLAY annual EBIT is now -673.06% below its all-time high of -$49.89 million, reached on December 31, 2018.

Performance

RLAY EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRLAYincome statement metrics

Quarterly EBIT:

-$80.39M-$3.54M(-4.61%)
September 30, 2025

Summary

  • As of today, RLAY quarterly earnings before interest & taxes is -$80.39 million, with the most recent change of -$3.54 million (-4.61%) on September 30, 2025.
  • Over the past year, RLAY quarterly EBIT has increased by +$15.98 million (+16.58%).
  • RLAY quarterly EBIT is now -329.77% below its all-time high of $34.99 million, reached on December 31, 2020.

Performance

RLAY Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRLAYincome statement metrics

TTM EBIT:

-$327.09M+$15.98M(+4.66%)
September 30, 2025

Summary

  • As of today, RLAY TTM earnings before interest & taxes is -$327.09 million, with the most recent change of +$15.98 million (+4.66%) on September 30, 2025.
  • Over the past year, RLAY TTM EBIT has increased by +$67.87 million (+17.18%).
  • RLAY TTM EBIT is now -1894.18% below its all-time high of -$16.40 million, reached on March 31, 2019.

Performance

RLAY TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRLAYincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

RLAY EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-1.6%+16.6%+17.2%
3Y3 Years-69.9%+2.7%-11.1%
5Y5 Years-358.9%-119.6%-180.5%

RLAY EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-69.9%at low-7.5%+28.3%-11.1%+17.2%
5Y5-Year-591.2%at low-329.8%+28.3%-486.2%+17.2%
All-TimeAll-Time-673.1%at low-329.8%+28.3%-1894.2%+17.2%

RLAY EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
-$80.39M(-4.6%)
-$327.09M(+4.7%)
Jun 2025
-
-$76.85M(+9.5%)
-$343.06M(+9.3%)
Mar 2025
-
-$84.87M(+0.1%)
-$378.35M(+1.9%)
Dec 2024
-$385.67M(-1.6%)
-$84.98M(+11.8%)
-$385.67M(+2.4%)
Sep 2024
-
-$96.37M(+14.1%)
-$394.96M(-5.8%)
Jun 2024
-
-$112.13M(-21.6%)
-$373.37M(-1.1%)
Mar 2024
-
-$92.19M(+2.2%)
-$369.44M(+2.6%)
Dec 2023
-$379.42M(-22.0%)
-$94.26M(-26.1%)
-$379.42M(-2.9%)
Sep 2023
-
-$74.78M(+30.9%)
-$368.55M(+2.1%)
Jun 2023
-
-$108.20M(-5.9%)
-$376.41M(-8.8%)
Mar 2023
-
-$102.18M(-22.5%)
-$345.82M(-11.2%)
Dec 2022
-$310.95M
-$83.39M(-0.9%)
-$310.95M(-5.6%)
Sep 2022
-
-$82.63M(-6.5%)
-$294.44M(-8.7%)
Jun 2022
-
-$77.61M(-15.3%)
-$270.80M(-7.9%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$67.32M(-0.6%)
-$250.99M(-11.0%)
Dec 2021
-$227.01M(-306.9%)
-$66.89M(-13.4%)
-$226.08M(-82.0%)
Sep 2021
-
-$58.99M(-2.1%)
-$124.21M(-22.0%)
Jun 2021
-
-$57.80M(-36.3%)
-$101.83M(-41.9%)
Mar 2021
-
-$42.41M(-221.2%)
-$71.74M(-28.6%)
Dec 2020
-$55.80M(+33.6%)
$34.99M(+195.6%)
-$55.80M(+52.2%)
Sep 2020
-
-$36.61M(-32.1%)
-$116.62M(-14.4%)
Jun 2020
-
-$27.72M(-4.8%)
-$101.92M(-8.3%)
Mar 2020
-
-$26.46M(-2.4%)
-$94.10M(-12.0%)
Dec 2019
-$84.05M(-68.5%)
-$25.83M(-17.9%)
-$84.05M(-44.4%)
Sep 2019
-
-$21.91M(-10.1%)
-$58.22M(-60.3%)
Jun 2019
-
-$19.91M(-21.4%)
-$36.31M(-121.4%)
Mar 2019
-
-$16.40M
-$16.40M
Dec 2018
-$49.89M
-
-

FAQ

  • What is Relay Therapeutics, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Relay Therapeutics, Inc.?
  • What is Relay Therapeutics, Inc. annual EBIT year-on-year change?
  • What is Relay Therapeutics, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Relay Therapeutics, Inc.?
  • What is Relay Therapeutics, Inc. quarterly EBIT year-on-year change?
  • What is Relay Therapeutics, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Relay Therapeutics, Inc.?
  • What is Relay Therapeutics, Inc. TTM EBIT year-on-year change?

What is Relay Therapeutics, Inc. annual earnings before interest & taxes?

The current annual EBIT of RLAY is -$385.67M

What is the all-time high annual EBIT for Relay Therapeutics, Inc.?

Relay Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$49.89M

What is Relay Therapeutics, Inc. annual EBIT year-on-year change?

Over the past year, RLAY annual earnings before interest & taxes has changed by -$6.25M (-1.65%)

What is Relay Therapeutics, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of RLAY is -$80.39M

What is the all-time high quarterly EBIT for Relay Therapeutics, Inc.?

Relay Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $34.99M

What is Relay Therapeutics, Inc. quarterly EBIT year-on-year change?

Over the past year, RLAY quarterly earnings before interest & taxes has changed by +$15.98M (+16.58%)

What is Relay Therapeutics, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of RLAY is -$327.09M

What is the all-time high TTM EBIT for Relay Therapeutics, Inc.?

Relay Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$16.40M

What is Relay Therapeutics, Inc. TTM EBIT year-on-year change?

Over the past year, RLAY TTM earnings before interest & taxes has changed by +$67.87M (+17.18%)
On this page